Mannose is a simple sugar closely related to glucose. It occurs naturally in small amounts in fruits like oranges, apples, and peaches, and your body already has it circulating in your blood at low concentrations. While it plays a quiet but essential role in how your cells build and maintain proteins, mannose has gained mainstream attention primarily as a supplement marketed for preventing urinary tract infections.
How Mannose Differs From Glucose
Mannose is a six-carbon sugar, placing it in the same chemical family as glucose. The two molecules are nearly identical, differing only in the orientation of a single chemical group at one position on the carbon chain. That tiny structural difference gives mannose distinct biological behavior. Your body processes it through different pathways, and most ingested mannose passes through you relatively quickly rather than being burned for energy the way glucose is. It’s found naturally in human blood plasma at concentrations of 50 to 100 micromoles per liter, a fraction of what you’d see with glucose.
Free mannose shows up in small quantities across many common foods. Oranges, apples, and peaches all contain trace amounts. Coffee beans, fenugreek, and guar gums are rich in mannose-containing compounds called galactomannans, but the human digestive tract can’t break these down efficiently, so they provide very little usable mannose. Historically, the original industrial source of mannose was ivory nut shavings, from a plant material so hard it was used to manufacture buttons.
What Mannose Does in Your Body
Inside your cells, mannose serves as a building block for glycoproteins, which are proteins decorated with sugar chains. These sugar chains are critical for protein folding, cell signaling, and immune function. The process of attaching sugars to proteins, called glycosylation, depends on mannose at several steps. When this process goes wrong due to genetic mutations, it leads to a group of rare inherited conditions called congenital disorders of glycosylation, which can cause serious problems with organ development and function.
One of these rare conditions, called MPI-CDG (mannose phosphate isomerase deficiency), is notable because it’s one of the few glycosylation disorders that responds to a straightforward treatment: oral mannose supplements. Patients with MPI-CDG primarily experience gastrointestinal and liver problems rather than the neurological issues seen in other glycosylation disorders. Supplemental mannose bypasses their enzymatic defect, normalizing many of their symptoms.
The UTI Connection
The reason most people encounter mannose in a health store has nothing to do with glycoproteins. D-mannose supplements are widely sold for preventing urinary tract infections, and the proposed mechanism is straightforward. The bacterium E. coli, responsible for the majority of UTIs, latches onto the bladder wall using tiny hair-like structures called type I pili. The tips of these pili have a protein called FimH that specifically binds to mannose-containing molecules on the surface of bladder cells.
The idea behind supplementation is competitive inhibition. When you take D-mannose orally, some of it is excreted in your urine. Free mannose molecules in the urine could theoretically saturate the FimH binding sites on the bacteria, preventing them from attaching to the bladder wall. Bacteria that can’t attach get flushed out when you urinate. Lab studies and animal models have confirmed that mannose can block this bacterial binding.
What the Clinical Evidence Actually Shows
The leap from lab dish to real-world prevention has proven more complicated. A large randomized clinical trial published in JAMA Internal Medicine followed 598 women with recurrent UTIs in primary care settings. Women who took daily D-mannose for six months had a UTI recurrence rate of 51%, compared to 55.7% in the placebo group. That’s a small, statistically insignificant difference. An earlier, smaller trial by Kranjcec and colleagues did find a meaningful reduction in recurrence, but subsequent trials have not replicated that result.
A 2025 meta-analysis pooling data from multiple randomized controlled trials concluded that D-mannose prophylaxis “did not cause any difference in the risk of recurrent UTI during follow-up and adverse events in adult women.” The inconsistency between studies is reflected in high statistical variability across the results. For comparison, in one trial that included an antibiotic prevention arm, about 14.6% of women on the antibiotic experienced recurrence versus 60% in usual care, a much more pronounced effect than anything D-mannose delivered.
Cell-level research also suggests mannose may have limitations. A study published in Frontiers in Microbiology found that while cranberry extract protected urinary tract cells from E. coli-induced damage (including oxidative stress and disruption of cell barriers), D-mannose did not show these protective effects under the same conditions. Both cranberry and mannose can interfere with bacterial binding, but cranberry appears to offer additional layers of cellular protection that mannose does not.
Safety and Metabolic Effects
D-mannose is generally well tolerated. The most common side effects are mild digestive symptoms like bloating or loose stools, which makes sense given that it’s a sugar passing through your gut largely unabsorbed. Clinical trials have not identified serious adverse events at standard supplement doses.
For people concerned about blood sugar, the picture is surprisingly reassuring. Research from the NIH found that D-mannose actually helped stabilize blood sugar in animal studies rather than raising it. In mice prone to type 1 diabetes, those given D-mannose in their drinking water were far less likely to develop the disease: 90% of control mice developed diabetes by 12 weeks, while most mannose-treated animals remained healthy even at 23 weeks. The mechanism appears to involve immune regulation. D-mannose boosted the activity of regulatory immune cells that prevent the autoimmune destruction of insulin-producing cells. The NIH team has also found evidence that D-mannose may play a role in suppressing obesity, a key factor in type 2 diabetes. These findings are from animal research and haven’t yet been confirmed in human clinical trials, but they suggest mannose is not metabolically harmful in the way you might expect a sugar to be.
Supplement Forms and Typical Doses
D-mannose supplements come as powders and capsules, typically sold in health food stores and pharmacies. For UTI prevention, the doses used in clinical trials generally range from 1.5 to 2 grams per day, taken either as a single dose or split across the day. For the rare condition MPI-CDG, therapeutic doses are much higher and precisely calculated (150 to 170 mg per kilogram of body weight, four to five times daily), but this is a medically supervised treatment for a specific genetic disease.
Because D-mannose is classified as a supplement rather than a drug, products vary in quality and aren’t subject to the same regulatory oversight as medications. If you’re considering it for recurrent UTIs, the current weight of clinical evidence suggests the benefit is modest at best and may not exceed what a placebo provides. Cranberry products, while also showing variable results in clinical trials, appear to offer broader protective mechanisms at the cellular level.